Success and Complication Rates After Sacral Neuromodulation for Fecal Incontinence and Constipation: A Single-center Follow-up Study.
Constipation
Electric stimulation
Fecal incontinence
Sacral nerve stimulation
Sacral neuromodulation
Journal
Journal of neurogastroenterology and motility
ISSN: 2093-0879
Titre abrégé: J Neurogastroenterol Motil
Pays: Korea (South)
ID NLM: 101530189
Informations de publication
Date de publication:
31 Jan 2019
31 Jan 2019
Historique:
received:
01
09
2018
revised:
28
09
2018
accepted:
09
10
2018
entrez:
16
1
2019
pubmed:
17
1
2019
medline:
17
1
2019
Statut:
ppublish
Résumé
The aim of this study was to evaluate the sustainability of sacral neuromodulation (SNM) success in patients with fecal incontinence (FI) and/or constipation. This is a retrospective analysis of a prospective database of patients who received SNM therapy for FI and/or constipation between 2006 and 2015. Success rates, complications and reintervention rates were assessed after up to 10 years of follow-up. Electrodes for test stimulation were implanted in 101 patients, of whom 79 (78.2%) received permanent stimulation. The mean follow-up was 4.4 ± 3.0 years. At the end of follow-up, 57 patients (72.2%) were still receiving SNM. The 5-year success rate for FI and isolated constipation was 88.2% (95% confidence interval [CI], 80.1-97.0%) and 31.2% (95% CI, 10.2-95.5%), respectively ( SNM offers an effective sustainable treatment for FI. For constipation, lasting success of SNM is limited and is thus not recommended. Reinterventions are necessary but do not impede treatment success.
Sections du résumé
BACKGROUND/AIMS
OBJECTIVE
The aim of this study was to evaluate the sustainability of sacral neuromodulation (SNM) success in patients with fecal incontinence (FI) and/or constipation.
METHODS
METHODS
This is a retrospective analysis of a prospective database of patients who received SNM therapy for FI and/or constipation between 2006 and 2015. Success rates, complications and reintervention rates were assessed after up to 10 years of follow-up.
RESULTS
RESULTS
Electrodes for test stimulation were implanted in 101 patients, of whom 79 (78.2%) received permanent stimulation. The mean follow-up was 4.4 ± 3.0 years. At the end of follow-up, 57 patients (72.2%) were still receiving SNM. The 5-year success rate for FI and isolated constipation was 88.2% (95% confidence interval [CI], 80.1-97.0%) and 31.2% (95% CI, 10.2-95.5%), respectively (
CONCLUSIONS
CONCLUSIONS
SNM offers an effective sustainable treatment for FI. For constipation, lasting success of SNM is limited and is thus not recommended. Reinterventions are necessary but do not impede treatment success.
Identifiants
pubmed: 30646487
pii: jnm17106
doi: 10.5056/jnm17106
pmc: PMC6326196
doi:
Types de publication
Journal Article
Langues
eng
Pagination
159-170Références
Am J Gastroenterol. 1999 Dec;94(12):3530-40
pubmed: 10606315
Dis Colon Rectum. 2000 Jan;43(1):9-16; discussion 16-7
pubmed: 10813117
Gastroenterology. 2001 Sep;121(3):536-41
pubmed: 11522736
Dis Colon Rectum. 2001 Sep;44(9):1261-7
pubmed: 11584196
Br J Surg. 2002 Dec;89(12):1570-1
pubmed: 12445068
Br J Surg. 2005 Nov;92(11):1423-31
pubmed: 16044426
Dis Colon Rectum. 2007 Jan;50(1):3-12
pubmed: 17080278
Dis Colon Rectum. 2008 May;51(5):494-502
pubmed: 18278532
Gastroenterology. 2009 Mar;136(3):741-54
pubmed: 19166855
Dis Colon Rectum. 2009 Jan;52(1):11-7
pubmed: 19273950
Dis Colon Rectum. 2009 Jul;52(7):1234-9
pubmed: 19571698
Ann Surg. 2010 Mar;251(3):441-9
pubmed: 20160636
Colorectal Dis. 2011 Sep;13(9):1030-4
pubmed: 20718837
Colorectal Dis. 2011 Aug;13(8):e203-11
pubmed: 21689312
Colorectal Dis. 2011 Aug;13(8):e196-202
pubmed: 21689329
Dis Colon Rectum. 2011 Sep;54(9):1065-75
pubmed: 21825885
Colorectal Dis. 2012 Jun;14(6):753-9
pubmed: 21883814
Dis Colon Rectum. 2011 Nov;54(11):1443-60
pubmed: 21979192
Dis Colon Rectum. 2012 Jan;55(1):26-31
pubmed: 22156864
Ann Surg. 2012 Apr;255(4):643-9
pubmed: 22418005
J Neurogastroenterol Motil. 2012 Oct;18(4):373-84
pubmed: 23105997
Dis Colon Rectum. 2013 Feb;56(2):234-45
pubmed: 23303153
Urology. 1990 May;35(5):388-92
pubmed: 2336766
Dis Colon Rectum. 2013 Jul;56(7):915-20
pubmed: 23739200
Ann Surg. 2014 Jun;259(6):1126-31
pubmed: 23817505
Dis Colon Rectum. 2014 Jun;57(6):772-80
pubmed: 24807603
Colorectal Dis. 2015 Apr;17(4):O74-87
pubmed: 25603960
Br J Surg. 2015 Mar;102(4):407-15
pubmed: 25644687
Neurogastroenterol Motil. 2015 May;27(5):734-9
pubmed: 25810166
Colorectal Dis. 2015 Sep;17(9):762-71
pubmed: 25846836
Am J Gastroenterol. 2015 May;110(5):733-40
pubmed: 25895520
Cochrane Database Syst Rev. 2015 Aug 24;(8):CD004464
pubmed: 26299888
Dis Colon Rectum. 2015 Dec;58(12):1194-209
pubmed: 26544818
Int J Colorectal Dis. 2016 Feb;31(2):439-44
pubmed: 26552785
Dis Colon Rectum. 2016 Jan;59(1):48-53
pubmed: 26651112
Int J Colorectal Dis. 2016 May;31(5):1005-1010
pubmed: 26833472
World J Gastrointest Pharmacol Ther. 2016 May 6;7(2):294-305
pubmed: 27158546
ANZ J Surg. 2017 Jun;87(6):462-466
pubmed: 27193192
Tech Coloproctol. 2017 Apr;21(4):277-286
pubmed: 28429130
Lancet. 1995 Oct 28;346(8983):1124-7
pubmed: 7475602
Eur Urol. 1993;24(1):72-6
pubmed: 8396034
Dis Colon Rectum. 1993 Jan;36(1):77-97
pubmed: 8416784